NCT01314664终止不适用
A PROSPECTIVE REGISTRY TO ASSESS THE EFFECTIVENESS AND LOCAL TOLERABILITY OF INTRAVESICAL VALRUBICIN IN SUBJECTS WITH NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC)
Endo Pharmaceuticals10 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2011年5月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 发起方
- 入组人数
- 15
- 试验地点
- 10
研究概览
简要总结
The purpose of this study is to observe and describe the effectiveness and local tolerability of intravesical treatment with valrubicin for non-muscle invasive bladder cancer (NMIBC) in a cohort of subjects treated under routine practice conditions.
研究设计
- 研究类型
- Observational
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Males and females 18 years of age and older
- •Diagnosed with NMIBC
- •Prescribed intravesical valrubicin to treat NMIBC
- •Understood and signed Informed Consent to participate
排除标准
- 未提供
研究者
研究点 (10)
Loading locations...
相似试验
已完成
不适用
Feasibility of M-health Version of "What Were We Thinking" Intervention to Promote Maternal Postpartum Mental HealthDepression, PostpartumAnxiety Disorders and SymptomsMaternal BehaviorNCT04847076Universidad del Desarrollo128
撤回
不适用
Observational Prospective Registry of the Efficacy, Safety, and Adherence to Infergen® in Patients Infected With Hep CHepatitis CNCT00951223Kadmon Corporation, LLC
已完成
不适用
Observational Study to Assess the Adequacy of Methadone Dosage, in Heroin Addicted Patients in a MMT.Heroin AddictionNCT02062736L.Molteni & C. dei F.lli Alitti-Soc. di Esercizio S.p.A.500
已完成
1 期
Prospective study on the effectiveness assessment of Indocyanine Green Lymphography and Lymphatic Surgery for lymphedema and lymphatic disease.ymphedema and lymphatic disease, chylous thoracs and ascitesJPRN-UMIN000021762Saiseikai Kawaguchi General Hospital200
已完成
1 期
Prospective study on the effectiveness assessment of Indocyanine Green Lymphography and Lymphatic Surgery for lymphedema and lymphatic disease.ymphedema and lymphatic diseaseJPRN-UMIN000022973Saiseikai Kawaguchi General Hospital. Department of lymphatic and reconstructive surgery.200
